Fuller & Thaler Asset Management’s PDL BioPharma, Inc. PDLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,129,470
| Closed | -$3.56M | – | 550 |
|
|
2020
Q3 | $3.56M | Sell |
1,129,470
-56,630
| -5% | -$178K | 0.05% | 247 |
|
|
2020
Q2 | $3.45M | Sell |
1,186,100
-30,590
| -3% | -$89K | 0.05% | 246 |
|
|
2020
Q1 | $3.43M | Buy |
1,216,690
+107,545
| +10% | +$303K | 0.06% | 219 |
|
|
2019
Q4 | $3.6M | Buy |
1,109,145
+3,175
| +0.3% | +$10.3K | 0.04% | 241 |
|
|
2019
Q3 | $2.39M | Sell |
1,105,970
-137,155
| -11% | -$296K | 0.03% | 264 |
|
|
2019
Q2 | $3.9M | Sell |
1,243,125
-6,915
| -0.6% | -$21.7K | 0.05% | 222 |
|
|
2019
Q1 | $4.65M | Buy |
1,250,040
+18,310
| +1% | +$68.1K | 0.06% | 197 |
|
|
2018
Q4 | $3.57M | Buy |
1,231,730
+20,580
| +2% | +$59.7K | 0.05% | 206 |
|
|
2018
Q3 | $3.19M | Hold |
1,211,150
| – | – | 0.03% | 259 |
|
|
2018
Q2 | $2.83M | Sell |
1,211,150
-150
| -0% | -$351 | 0.03% | 268 |
|
|
2018
Q1 | $3.56M | Sell |
1,211,300
-86,000
| -7% | -$253K | 0.04% | 233 |
|
|
2017
Q4 | $3.56M | Sell |
1,297,300
-404,200
| -24% | -$1.11M | 0.04% | 207 |
|
|
2017
Q3 | $5.77M | Sell |
1,701,500
-8,000
| -0.5% | -$27.1K | 0.07% | 156 |
|
|
2017
Q2 | $4.22M | Buy |
1,709,500
+1,004,700
| +143% | +$2.48M | 0.06% | 167 |
|
|
2017
Q1 | $1.6M | Buy |
+704,800
| New | +$1.6M | 0.02% | 237 |
|